Lexi-Comp, Inc.
Show Cart Shopping Cart
Login to Lexi-Comp ONLINE »
Solutions for Institutions »

New Drugs

This page illustrates Lexi-Comp's commitment to its publishing model. Our online and handheld drug databases are updated daily, providing timely information on medications and vital healthcare topics.

Below is a list of new drug approvals and new combination monographs that have been added to Lexi-Comp's main drug database within the last 12 months.

View Complete Monographs

New drug monographs are available immediately to subscribers of Lexi-Comp ONLINE, and Lexi-Comp ON-HAND, our handheld software.  Request a free demo of Lexi-Comp software and see why thousands of practitioners rely on our resources.

View an example of a monograph in Lexi-Comp ONLINE.

New Drug Approvals

Amino Acid Injection 11/13/08
Lacosamide 11/5/08
Difluprednate 10/6/08
Rivaroxaban 9/30/08
Ceftobiprole 9/16/08
Romiplostim 8/27/08
Clevidipine 8/19/08
Regadenoson 6/17/08
L-Methylfolate 6/4/08
Desvenlafaxine 5/30/08
Alvimopan 5/28/08
Methylnaltrexone 5/20/08
Levoleucovorin 5/14/08
Certolizumab Pegol 4/28/08
Bendumustine 4/3/08
Rilonacept 3/11/08
Fosaprepitant 2/4/08
Etravirine 1/23/08
Nebivolol 1/10/08
Sapropterin 12/7/07
Nilotinib 11/7/07
Doripenem 10/7/07
Ixabepilone 10/7/07
Raltegravir 10/7/07
Armodafinil 9/7/07

New Drug Combinations

Methenamine, Phenyl Salicylate, Methylene Blue, Benzoic Acid, and Hyoscyamine 11/4/08
Repaglinide and Metformin 8/21/08
Sumatriptan & Naproxen 5/29/08
Niacin and Simvastatin 3/5/08
Aliskiren and Hydrochlorothiazide 2/6/08
Amlodipine and Olmesartan 11/7/07
Special Alerts

Find out about important drug information.

Go »

Errors and Omissions

Accurate records of errors and omissions in our print products.

Go »

View Monographs Instantly

Request a FREE 45-Day Trial of Lexi-Comp ONLINE

Request a FREE Demo of Lexi-Comp ON-HAND

Or, request Sales contact Go »

© Lexi-Comp, Inc.
All Rights Reserved.
1100 Terex Road | Hudson, Ohio 44236
330.650.6506 (Corporate)
Lexi-Comp, Inc. - Clear. Concise. Accurate.